Seegene Inc (096530):医療機器:M&Aディール及び事業提携情報

【英語タイトル】Seegene Inc (096530) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C6494)・商品コード:DATA904C6494
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:27
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥79,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Seegene Inc (Seegene) is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions using Real-time PCR methods. Seegene’s IVD reagents are used in testing respiratory pathogen, gastrointestinal pathogen, sexually transmitted infections, human papillomavirus, tuberculosis and sepsis and meningitis pathogen, among others. The company caters to commercial laboratories, DNA chip-based companies and molecular diagnostic companies. It has operations in the US, Canada, Germany and others. Seegene is headquartered in Seoul, South Korea.

Seegene Inc (096530) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Seegene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Seegene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Seegene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Seegene Inc, Medical Equipment, Deal Details 10
Partnerships 10
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 10
Seegene to Enter into Agreement with Hamilton 11
Seegene Enters into Agreement with Thermo Fisher Scientific 12
Seegene and Institut Catala d’Oncologia Enter into Partnership 13
Seegene Enters into Agreement with Hologic 14
Seegene Forms Joint Venture with Biodist 15
Seegene Enters into Co-Development Agreement with BD Life Sciences 16
Seegene To Enter Into Development Agreement For Real-Time Array Technology 17
Seegene Enters Into Distribution Agreement With Eidia For Multiplex Molecular Diagnostic Tests 18
Seegene And Selventa Enter Into Agreement To Develop Molecular Diagnostics 19
Seegene Enters Into Co-Development Agreement With DuPont Nutrition & Health To Develop Multiplexed Assays For Food Safety Testing 20
Seegene Inc – Key Competitors 21
Seegene Inc – Key Employees 22
Seegene Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 23
Recent Developments 24
Product News 24
Jan 03, 2018: Seegene develops world’s first multiplex MDx assays with its AI system 24
Apr 26, 2017: Seegene Unlocks the Door to the Next Level of the Real-time PCR Business 25
Feb 14, 2017: Seegene Develops New Normalization Software Technology for Molecular Diagnosis 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Seegene Inc, Medical Equipment, Key Facts, 2017 2
Seegene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Seegene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Seegene Inc, Deals By Market, 2012 to YTD 2018 8
Seegene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 10
Seegene to Enter into Agreement with Hamilton 11
Seegene Enters into Agreement with Thermo Fisher Scientific 12
Seegene and Institut Catala d'Oncologia Enter into Partnership 13
Seegene Enters into Agreement with Hologic 14
Seegene Forms Joint Venture with Biodist 15
Seegene Enters into Co-Development Agreement with BD Life Sciences 16
Seegene To Enter Into Development Agreement For Real-Time Array Technology 17
Seegene Enters Into Distribution Agreement With Eidia For Multiplex Molecular Diagnostic Tests 18
Seegene And Selventa Enter Into Agreement To Develop Molecular Diagnostics 19
Seegene Enters Into Co-Development Agreement With DuPont Nutrition & Health To Develop Multiplexed Assays For Food Safety Testing 20
Seegene Inc, Key Competitors 21
Seegene Inc, Key Employees 22
Seegene Inc, Other Locations 23
Seegene Inc, Subsidiaries 23
Seegene Inc, Joint Venture 23

List of Figures
Seegene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Seegene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Seegene Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★調査レポート[Seegene Inc (096530):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C6494)販売に関する免責事項を必ずご確認ください。
★調査レポート[Seegene Inc (096530):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆